June 2017
Volume 58, Issue 8
Open Access
ARVO Annual Meeting Abstract  |   June 2017
Secretion of Down Syndrome Critical Region 1 Isoform4 in ischemic retinal ganglion cells displays anti-angiogenic properties via NFATc1-dependent pathway
Author Affiliations & Notes
  • yue xu
    Zhongshan Ophthalmic Center, Sun Yat-sen University, Guang Zhou, China
  • Yaguang Hu
    Zhongshan Ophthalmic Center, Sun Yat-sen University, Guang Zhou, China
  • Xiaoling Liang
    Zhongshan Ophthalmic Center, Sun Yat-sen University, Guang Zhou, China
  • Footnotes
    Commercial Relationships   yue xu, None; Yaguang Hu, None; Xiaoling Liang, None
  • Footnotes
    Support  Chinese government provided financial support in the form of the National Natural Science Foundation of China (No. 81470030, and No. 81670873)
Investigative Ophthalmology & Visual Science June 2017, Vol.58, 1557. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      yue xu, Yaguang Hu, Xiaoling Liang; Secretion of Down Syndrome Critical Region 1 Isoform4 in ischemic retinal ganglion cells displays anti-angiogenic properties via NFATc1-dependent pathway. Invest. Ophthalmol. Vis. Sci. 2017;58(8):1557.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Down syndrome candidate region 1 (DSCR1) plays a role in number of physiological processes, such as inhibition of cardiachypertrophy, attenuation of angiogenesis and cancer, and protection against neuronal death, but the function of DSCR1 in the retina is still not clear. We hypothesize that DSCR1 may play an important role in ischemic retina via nuclear factor of activated T-cell (NFATc) 1-dependent pathway. In this study, we used an oxygen-induced retinopathy (OIR) model to analyze DSCR1 expression location in retina and its effects on angiogenesis.

Methods : The neonatal C57BL/6J mice were exposed to 75% O2 for 5 days from postnatal day 7 (P7) to P12. At P12, the mice were returned to 21 % O2 at room air. The primary retinal ganglion cells (RGCs) were exposed to hypoxia (93% N2, 5% CO2 and 2% O2) at 37°C for 36 hours (h). And then the mouse retinal microvascular endothelial cells (mRMECs) treated with 25 ng/mL vascular endothelial growth factor (VEGF) or culture medium conditioned by hypoxic RGCs alone, hypoxic RGCs treated with siRNA to DSCR1-4 (siDSCR1-4) or hypoxic RGCs treated with siDSCR1-4 and 200 ng/ml Cyclosporin A (CsA), and then primed with VEGF (25 ng/mL).

Results : The expression of DSCR1-4 increased strongly at P16 in OIR compared to the control. There was no change in mRNA expression of DSCR1-1 at P16 in OIR. The increased DSCR1 was mainly located in the RGCs of avascular retina. In addition, DSCR1-4 expression was increased in primary RGCs after hypoxia exposure. There was no change in mRNA expression of DSCR1-1 in primaryRGCs after hypoxia exposure. Moreover, DSCR1-4 produced by hypoxic RGCs showed anti-angiogenic properties, with decreased cell proliferation, migration, tube formation, inflammatory cytokines production. These properties were incurred from inhibiting NFATc1 dephosphorylation and translocation into nuclear in VEGF-induced mRMECs. Using siRNA-mediated knockdown of DSCR1-4 and NFATc1 inhibitor (CsA), we found that DSCR1-4 inhibited angiogenesis in VEGF-induced mRMECs, and this effect was NFATc1-dependent.

Conclusions : This report describes novel DSCR1-4 anti-angiogenic effects, suggesting potential therapeutic strategies for proliferative retinopathies.

This is an abstract that was submitted for the 2017 ARVO Annual Meeting, held in Baltimore, MD, May 7-11, 2017.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×